{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:55:49Z","timestamp":1774965349416,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,31]]},"DOI":"10.7759\/cureus.106186","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:06:06Z","timestamp":1774962366000},"source":"Crossref","is-referenced-by-count":0,"title":["Anemia Management in a Jehovah's Witness Patient With Hip Fracture"],"prefix":"10.7759","author":[{"given":"Catarina Morete","family":"Cabrita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreia","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Serra Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"How many of Jehovah's Witnesses are there worldwide?. (2024). Accessed. January 21, 2025: https:\/\/www.jw.org\/en\/jehovahs-witnesses\/faq\/how-many-jw\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-015-0185-9","article-title":"Hidden blood loss and its influential factors after total hip arthroplasty","volume":"10","author":"Miao K","year":"2015","unstructured":"Miao K, Ni S, Zhou X, Xu N, Sun R, Zhuang C, Wang Y. Hidden blood loss and its influential factors after total hip arthroplasty. J Orthop Surg Res. 2015, 10:36. 10.1186\/s13018-015-0185-9","journal-title":"J Orthop Surg Res"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.55095\/achot2013\/035","article-title":"Multivariate analysis of blood loss during primary total hip or knee arthroplasty [Article in Czech]","volume":"80","author":"Lo\u0161\u0165\u00e1k J","year":"2013","unstructured":"Lo\u0161\u0165\u00e1k J, Gallo J, Ml\u010d\u016fchov\u00e1 D. Multivariate analysis of blood loss during primary total hip or knee arthroplasty [Article in Czech]. Acta Chir Orthop Traumatol Cech. 2013, 80:219-25.","journal-title":"Acta Chir Orthop Traumatol Cech"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.artd.2020.10.006","article-title":"Routine type and screens are unnecessary for primary total hip and knee arthroplasties at an academic hospital","volume":"6","author":"Christopher ZK","year":"2020","unstructured":"Christopher ZK, Bruce MR, Reynolds EG, Spangehl MJ, Bingham JS, Kraus MB. Routine type and screens are unnecessary for primary total hip and knee arthroplasties at an academic hospital. Arthroplast Today. 2020, 6:941-4. 10.1016\/j.artd.2020.10.006","journal-title":"Arthroplast Today"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2024.09.035","article-title":"Bloodless total hip arthroplasty in Jehovah's Witness patients: contemporary strategies and outcomes","volume":"40","author":"Shen V","year":"2025","unstructured":"Shen V, Salomon KI, Ohanisian LL, Simon P, Miranda MA, Bernasek TL. Bloodless total hip arthroplasty in Jehovah's Witness patients: contemporary strategies and outcomes. J Arthroplasty. 2025, 40:964-70. 10.1016\/j.arth.2024.09.035","journal-title":"J Arthroplasty"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1353994","article-title":"Blood management strategies in primary and revision total knee arthroplasty for Jehovah's Witness patients","volume":"26","author":"Issa K","year":"2013","unstructured":"Issa K, Banerjee S, Rifai A, Kapadia BH, Harwin SF, McInerney VK, Mont MA. Blood management strategies in primary and revision total knee arthroplasty for Jehovah's Witness patients. J Knee Surg. 2013, 26:401-4. 10.1055\/s-0033-1353994","journal-title":"J Knee Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-200211000-00003","article-title":"Perioperative blood management practices in elective orthopaedic surgery","volume":"10","author":"Keating EM","year":"2002","unstructured":"Keating EM, Meding JB. Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg. 2002, 10:393-400. 10.5435\/00124635-200211000-00003","journal-title":"J Am Acad Orthop Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/23247096241231649","article-title":"Management of severe anemia in a Jehovah's Witness patient with lung abscess secondary to malpositioned laparoscopic adjustable gastric band: a case report","volume":"12","author":"Ruan N","year":"2024","unstructured":"Ruan N, Shi C, Al-Momani Z, Jaber F, Ghaly R, Wooldridge D. Management of severe anemia in a Jehovah's Witness patient with lung abscess secondary to malpositioned laparoscopic adjustable gastric band: a case report. J Investig Med High Impact Case Rep. 2024, 12:23247096241231649. 10.1177\/23247096241231649","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref9","article-title":"Allogeneic transfusion and infection: economic and clinical implications","volume":"34","author":"Blumberg N","year":"1997","unstructured":"Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol. 1997, 34:34-40.","journal-title":"Semin Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005721","article-title":"Recommendations from the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS)","volume":"277","author":"Shander A","year":"2023","unstructured":"Shander A, Corwin HL, Meier J, et al.. Recommendations from the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS). Ann Surg. 2023, 277:581-90. 10.1097\/SLA.0000000000005721","journal-title":"Ann Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/sdi.12569","article-title":"Target-based anemia management with erythropoiesis stimulating agents (risks and benefits relearned) and iron (still more to learn)","volume":"30","author":"Stivelman JC","year":"2017","unstructured":"Stivelman JC. Target-based anemia management with erythropoiesis stimulating agents (risks and benefits relearned) and iron (still more to learn). Semin Dial. 2017, 30:142-8. 10.1111\/sdi.12569","journal-title":"Semin Dial"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464050-00004","article-title":"Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease","volume":"64","author":"Deicher R","year":"2004","unstructured":"Deicher R, H\u00f6rl WH. Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease. Drugs. 2004, 64:499-509. 10.2165\/00003495-200464050-00004","journal-title":"Drugs"},{"key":"ref13","unstructured":"Summary of product characteristics. (2024). Accessed. 2025: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/neorecormon-epar-product-information_en.pdf."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S159134","article-title":"A meta-analysis and systematic review evaluating the use of erythropoietin in total hip and knee arthroplasty","volume":"14","author":"Li Y","year":"2018","unstructured":"Li Y, Yin P, Lv H, Meng Y, Zhang L, Tang P. A meta-analysis and systematic review evaluating the use of erythropoietin in total hip and knee arthroplasty. Ther Clin Risk Manag. 2018, 14:1191-204. 10.2147\/TCRM.S159134","journal-title":"Ther Clin Risk Manag"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.07.014","article-title":"Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis","volume":"61","author":"Koulouridis I","year":"2013","unstructured":"Koulouridis I, Alfayez M, Trikalinos TA, Balk EM, Jaber BL. Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis. Am J Kidney Dis. 2013, 61:44-56. 10.1053\/j.ajkd.2012.07.014","journal-title":"Am J Kidney Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/475422-anemia-management-in-a-jehovahs-witness-patient-with-hip-fracture","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:06:08Z","timestamp":1774962368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/475422-anemia-management-in-a-jehovahs-witness-patient-with-hip-fracture"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.106186","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}